Azano Scientific Overview
- Year Founded
-
2007
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Azano Scientific General Information
Description
Developer of therapeutic drugs designed to treat Lupus and other autoimmune diseases. The company's therapeutic drugs include GPER ligands and C-reactive protein derivative, enabling patients with kidney failure to access improved treatment.
Contact Information
Website
www.azanoscientific.comFormerly Known As
Azano Pharmaceuticals
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
- 5901 Indian School Road North East
- Albuquerque, NM 87110
- United States
+1 (505)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
- 5901 Indian School Road North East
- Albuquerque, NM 87110
- United States
+1 (505)
Azano Scientific Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Apr-2016 | Completed | Out of Business | |||
| 3. Grant | 01-Jan-2010 | Completed | Startup | |||
| 2. Grant | 01-Jan-2009 | $53.9K | Completed | Startup | ||
| 1. Early Stage VC | 01-Jan-2007 | Completed | Startup |
Azano Scientific FAQs
-
When was Azano Scientific founded?
Azano Scientific was founded in 2007.
-
Where is Azano Scientific headquartered?
Azano Scientific is headquartered in Albuquerque, NM.
-
What industry is Azano Scientific in?
Azano Scientific’s primary industry is Drug Discovery.
-
Is Azano Scientific a private or public company?
Azano Scientific is a Private company.
-
What is Azano Scientific’s current revenue?
The current revenue for Azano Scientific is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process